Zhejiang Wecome Pharmaceutical released the interim report for 2024, with operating revenue of 0.297 billion yuan, a year-on-year decrease of 6.15%; net income attributable to shareholders of listed companies was 14.1921 million yuan, a year-on-year decrease of 78.04%.
维康药业：上半年净利润1419.21万元 同比下降78.04%
Zhejiang Wecome Pharmaceutical: Net income in the first half of the year is 14.1921 million yuan, a year-on-year decrease of 78.04%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated